4//SEC Filing
Neuman Linda L 4
Accession 0001209191-23-005351
CIK 0001636282other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 6:20 PM ET
Size
5.6 KB
Accession
0001209191-23-005351
Insider Transaction Report
Form 4
Neuman Linda L
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-11-14+25,000→ 25,000 totalExercise: $1.36Exp: 2032-11-13→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock options will vest as to 1/4th of the total shares on November 14, 2023, and then 1/48th of the shares will vest monthly thereafter, such that the option will become fully vested on November 14, 2026, subject to the Reporting Person's provision of service to the issuer on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001951205
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 6:20 PM ET
- Size
- 5.6 KB